Evidence mapPaperPMID 41245403Full record

ArticleFrontiers in nutrition2025

Body composition as a complementary tool for detection of metabolic syndrome 6 years postpartum: a St. Carlos Cohort follow-up.

Bricia López-Plaza, Angélica Larrad-Sainz, Johanna Valerio, Rocío Martín O'Connor, Laura Del Valle, Ana M Ramos-Levi, Ana Barabash, Clara Marcuello, Inés Jiménez-Varas, Miguel A Rubio-Herrera and 2 more

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bricia López-Plaza *Departamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Angélica Larrad-Sainz *Departamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Johanna ValerioDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Rocío Martín O'ConnorDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Laura Del ValleDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Ana M Ramos-LeviDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Ana BarabashDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Clara MarcuelloDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Inés Jiménez-VarasDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Miguel A Rubio-HerreraDepartamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Pilar Matía-Martín *Departamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.
Alfonso L Calle-Pascual *Departamento de Endocrinología y Nutrición, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Gestational diabetes mellitus (GDM) is a prevalent pregnancy complication associated with long-term cardiometabolic risk, including metabolic syndrome (MetS). This study aimed to assess differences in body composition and metabolic health 6 years postpartum based on prior GDM diagnosis and to identify body composition cut-off values predictive of MetS. Methods: This cross-sectional analysis included 604 women from the prospective St. Carlos Cohort in Spain, who had no subsequent pregnancies and complete body composition data 6 years postpartum. Body composition was assessed using bioelectrical impedance analysis (BIA), and MetS was diagnosed per harmonized criteria. Statistical analyses included ROC curves to establish diagnostic accuracy and optimal cut-off points. Results: Women with prior GDM had a twofold increased risk of developing MetS (26.6 vs. 14.6%). However, waist circumference or elevated BMI and waist-to-height ratio were not significantly different between groups. ROC analysis identified that body composition parameters, particularly fat mass (FM), visceral fat, and FM/Fat Free Mass ratio, as having high predictive value for MetS, regardless of GDM history (AUC ≥ 0.8). Women with MetS showed significantly higher FM and lower relative muscle mass and function. Diagnostic models showed high negative predictive values (≥90%) for most body composition parameters making them effective for excluding MetS. Conclusion: GDM is a significant predictor of MetS. However, body composition, especially increased adiposity and reduced relative muscle mass, provides valuable clinical insights beyond traditional anthropometric measures in postpartum women. The proposed cut-off values for body composition parameters may serve as effective, non-invasive tools for early MetS detection in postpartum care.

Indexed as

body compositiongestational diabetes mellitusmetabolic syndromepostpartum periodprevalance

Identifiers

PMID41245403
PMCPMC12614464

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.